SULODEXIDEA PANACEA BIO CHEM RESEARCH PROGRAMME
MENU

COMPOSITION

Two fractions. Multiple regulatory systems.

Fast-moving heparin-like fraction

~80% of the complex

  • Antithrombin III relationship — the endogenous serine-protease inhibitor pathway
  • Activity involving coagulation proteases
  • Heparan-sulfate-like character
  • Endothelial-surface glycosaminoglycan relationship
  • Possible contribution to the glycocalyx hypothesis

Dermatan sulfate

~20% of the complex

  • Heparin cofactor II interaction
  • Thrombin regulation through a second endogenous pathway
  • Extracellular-matrix relevance
  • Complementary role within the complex

Sulodexide’s scientific identity lies in the interaction of two glycosaminoglycan fractions rather than one isolated pharmacological action.

Why characterisation matters

“Sulodexide” names a complex biological mixture. Fraction proportions, molecular-weight distribution, charge density, sulphation pattern, chromatographic behaviour, potency, impurities, batch consistency and anticoagulant activity all define what the substance in a given vial or capsule actually is. For a research programme, identity testing is not bureaucracy — it is the difference between studying a defined architecture and studying an assumption.

Composition and characterisation is research pillar 7 of the Panacea programme; the analytical methods themselves are part of the research output Panacea expects to develop.